RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/q9hgcwWtmu
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/q9hgcwWtmu
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/q9hgcwWtmu
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/q9hgcwWtmu
Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/q9hgcwWtmu
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/xDg4WpaROx
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/xDg4WpaROx
RT @atscommunity: Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/xDg4WpaROx
Reliever salbutamol use as a measure of exacerbation risk in #COPD: http://t.co/xDg4WpaROx
RT @RespEM: “@TCapper78: @JohnathanLaird How much salbutamol in COPD? MT @UKCPAResp: http://t.co/0l5UIIAhvw” perhaps a low tolerance. Ramp …
“@TCapper78: @JohnathanLaird How much salbutamol in COPD? MT @UKCPAResp: http://t.co/0l5UIIAhvw” perhaps a low tolerance. Ramp up Laban/lama
@JohnathanLaird @RespEM @asthmauk ..& following on from this, How much salbutamol is too much in COPD? MT @UKCPAResp: http://t.co/SyM2ncax7K
Short-acting β2-agonist (SABA) reliever use predict short- and long-term exacerbation risk in #COPD patients http://t.co/lpgZI4r8JI
High use of SABA predicts future risk of exacerbations in mod-severe #COPD http://t.co/d2lJ67JV5f